from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3204/-

LFCtreatmentdescriptionclass of inhibitor

-0.308

Amikacinug/mL Amikacintranslation

-0.543

Cap5-10ug/mL Capreomycintranslation

0.077

Rox10-50 ug/mL Roxithromycintranslation

-0.229

SM2-5 ug/mL Streptomycintranslation

0.157

Tet5-10 ug/mL Tetracyclinetranslation

0.524

Rif0.2-5ug/mL Rifampicintranscription

-0.826

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.805

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.209

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.739

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.090

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.254

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.198

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.669

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.143

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.258

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.465

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.540

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.118

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.305

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.959

KCN5-20 ug/mL Potassium cyaniderespiration

-1.233

NaN30.2-2 mM Sodium aziderespiration

0.855

Nigericin50 uM Nigericinrespiration

-0.470

TRC10-150 ug/mL Triclosanrespiration

-0.528

TRZ10-25 ug/mL Thioridazinerespiration

2.510

Valinomycin0.5-10 uM Valinomycinrespiration

0.126

ZnSO42 mM ZnSO4respiration

1.020

menadione6-10 ug/mL Menadionerespiration

-0.001

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.102

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.809

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.254

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.971

NRP_1Non-replicating persistence stage 1dosRassociated

-0.063

Amp0.2mg/mL AmpicillincellWall

-0.558

Cephalexin20-100 ug/mL CephalexincellWall

-0.584

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.441

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.929

EMB10-20 ug/mL EthambutolcellWall

-1.184

Eta12-40 ug/mL EthionamidecellWall

-1.093

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.411

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.167

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.178

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.772

BZA0.12 mg/mL BenzamidearomaticAmides

0.463

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.743

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.019

H2O24 mM hydrogen peroxideDNAdamaging

0.538

Levo10 ug/mL LevofloxacinDNAdamaging

-0.178

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.527

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.217

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.594

UVUV-irradiationDNAdamaging

-0.575

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.207

Antimycin12.5-50 ug/mL Antimycin A?

-0.364

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.583

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.549

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.046

PA8240.2-2 ug/mL PA-824?

0.305

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.271

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.560

Verapamil50 uM Verapamil?

-0.302

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.240

methoxatin10-20 ug/mL Methoxatin?